107 related articles for article (PubMed ID: 10687911)
1. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity.
Werkmeister R; Brandt B; Joos U
Br J Oral Maxillofac Surg; 1999 Dec; 37(6):477-80. PubMed ID: 10687911
[TBL] [Abstract][Full Text] [Related]
2. Gene copy numbers of erbB oncogenes in human pheochromocytoma.
Sworczak K; Zaczek A; Babinska A; Lisowska U; Bielawski KP; Falkiewicz B
Oncol Rep; 2002; 9(6):1373-8. PubMed ID: 12375051
[TBL] [Abstract][Full Text] [Related]
3. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
[TBL] [Abstract][Full Text] [Related]
4. Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes.
Roetger A; Brandt B; Barnekow A
DNA Cell Biol; 1997 Apr; 16(4):443-8. PubMed ID: 9150431
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53 gene as a biomarker of high risk oral leukoplakias.
Saranath D; Tandle AT; Deo MG; Mehta AR; Sanghvi V
Indian J Biochem Biophys; 1997 Jun; 34(3):266-73. PubMed ID: 9425746
[TBL] [Abstract][Full Text] [Related]
6. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis by oligonucleotide microarray in oral leukoplakia.
Kuribayashi Y; Morita K; Tomioka H; Uekusa M; Ito D; Omura K
J Oral Pathol Med; 2009 Apr; 38(4):356-61. PubMed ID: 19220711
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability and tumor-specific DNA alterations in oral leukoplakias.
Tanić N; Tanić N; Milasin J; Vukadinović M; Dimitrijević B
Eur J Oral Sci; 2009 Jun; 117(3):231-7. PubMed ID: 19583749
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias.
Prado SM; Cedrún JL; Rey RL; Villaamil VM; García AA; Ayerbes MV; Aparicio LA
Exp Mol Pathol; 2010 Oct; 89(2):197-203. PubMed ID: 20599939
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
12. Chromosome polysomy and histological characteristics in oral premalignant lesions.
Kim J; Shin DM; El-Naggar A; Lee JS; Corrales C; Lippman SM; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):319-25. PubMed ID: 11319171
[TBL] [Abstract][Full Text] [Related]
13. A qualitative and quantitative estimation of AgNORS in dysplastic and non-dysplastic leukoplakias.
Pandit S; Aithal D
Indian J Dent Res; 2002; 13(1):27-30. PubMed ID: 12420565
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
15. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
16. [Amplification of EMS1 gene in oral carcinogenesis].
Xia J; Li BQ; Zeng X; Chen QM; He Y; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):102-4. PubMed ID: 15842855
[TBL] [Abstract][Full Text] [Related]
17. The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism.
Bednarz N; Błaut K; Sworczak K; Oseka T; Bielawski KP
Acta Biochim Pol; 2009; 56(1):83-8. PubMed ID: 19259547
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cyclin D1, p27, and p63 in oral leukoplakia.
Kövesi G; Szende B
J Oral Pathol Med; 2006 May; 35(5):274-7. PubMed ID: 16630290
[TBL] [Abstract][Full Text] [Related]
19. Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma.
Kondoh N; Ohkura S; Arai M; Hada A; Ishikawa T; Yamazaki Y; Shindoh M; Takahashi M; Kitagawa Y; Matsubara O; Yamamoto M
Oral Oncol; 2007 May; 43(5):455-62. PubMed ID: 16979924
[TBL] [Abstract][Full Text] [Related]
20. Proliferative verrucous leukoplakia of the gingiva.
Fettig A; Pogrel MA; Silverman S; Bramanti TE; Da Costa M; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):723-30. PubMed ID: 11113818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
